Metformin (Metored, Metformin Xr Unimed, Metryxa Xr, Diamin)
Metformin
Unimed Healthcare (Pty) Ltd
Registration
- Applicant
- Unimed Healthcare (Pty) Ltd
- Registrations
- 11
- Schedule source
- Consolidated Schedules 06 July 2026
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Metored 500 EACH TABLET CONTAINS: METFORMIN HYDROCHLORIDE 500,0 mg | 500 | 41108941/21.2/1089 | Registered | S3 | None |
| Metored 850 EACH TABLET CONTAINS: METFORMIN HYDROCHLORIDE 850,0 mg | 850 | 41109041/21.2/1090 | Registered | S3 | None |
| Metored 1000 EACH TABLET CONTAINS: METFORMIN HYDROCHLORIDE 1000,0 mg | 1000 | 41109141/21.2/1091 | Registered | S3 | None |
| Metformin 500 MG xr unimed EACH TABLET CONTAINS: METFORMIN HYDROCHLORIDE 500,0 mg | 500 mgFilm-coated tablet | 58019058/21.2/0190Approved 22 May 2026 | Registered | S3 | PIPIL |
| Metformin 750 MG xr unimed EACH TABLET CONTAINS: METFORMIN HYDROCHLORIDE 750,0 mg | 750 mgFilm-coated tablet | 58019158/21.2/0191Approved 22 May 2026 | Registered | S3 | PIPIL |
| Metformin 1 000 MG xr unimed EACH TABLET CONTAINS: METFORMIN HYDROCHLORIDE 1 000,0 mg | 500 mg, 750 mg & 1000 mgFilm-coated tablet | 58019258/21.2/0192Approved 22 May 2026 | Registered | S3 | PIPIL |
| Metryxa 500 MG xr EACH TABLET CONTAINS: METFORMIN HYDROCHLORIDE 500,0 mg | 500 mgFilm-coated tablet | 580193.19058/21.2/0193.190Approved 22 May 2026 | Registered | S3 | PIPIL |
| Metryxa 750 MG xr EACH TABLET CONTAINS: METFORMIN HYDROCHLORIDE 750,0 mg | 750 mgFilm-coated tablet | 580194.19158/21.2/0194.191Approved 22 May 2026 | Registered | S3 | PIPIL |
| Metryxa 1 000 MG xr EACH TABLET CONTAINS: METFORMIN HYDROCHLORIDE 1 000,0 mg | 500 mg, 750 mg & 1000 mgFilm-coated tablet | 580195.19258/21.2/0195.192Approved 22 May 2026 | Registered | S3 | PIPIL |
| Diamin 500 EACH TABLET CONTAINS METFORMIN HYDROCHLORIDE 500,0 mg | 500Film-coated tablets. | A400464A40/21.2/0464Approved 3 March 2025 | Registered | S3 | PIPIL |
| Diamin 850 EACH TABLET CONTAINS METFORMIN HYDROCHLORIDE 850,0 mg | 850Film-coated tablets. | A400465A40/21.2/0465Approved 3 March 2025 | Registered | S3 | PIPIL |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Metformin hydrochloride
S3: Metformin
Consolidated Schedules 06 July 2026, line 3938
Pharmacological class: Oral hypoglycaemics. (class 21.2)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
3-(Diaminomethylidene)-1,1-dimethylguanidine
Drag to rotate. Structure from PubChem CID 4091.
SAHPRA documents
Schedule Verification
This medication's schedule (S3) has been verified from official SAHPRA documents with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.